Apelin-36 is the longest of the commonly used apelin isoforms and the closest to the full processed product of the apelin preproprotein. The supplied sequence shows that it contains the entire apelin-17 sequence at its C-terminus, extended by a further nineteen residues at the N-terminus. That N-terminal extension is what distinguishes it experimentally. The C-terminal region carries the APJ receptor-binding determinants shared across the isoform family, while the extension influences affinity, clearance and the signalling profile the receptor adopts. Apelin isoforms are not equipotent, and reports of biased agonism within the apelinergic system mean that an isoform can favour G protein or beta-arrestin pathways differently, which matters directly for work aimed at separating desired cardiovascular effects from receptor desensitisation. Because the longer form is closer to the species generated physiologically from the precursor, it is often preferred where the goal is to reproduce endogenous signalling rather than to maximise potency. For direct comparisons of chain-length effects on APJ, running it against apelin-17 (LT9290) under identical conditions is the cleanest design, since the two share their entire receptor-binding region. | 